Ertapenem Sodium

厄他培南钠

Report date: 2024/05/31 11:59:48
NME

Base Information

Drug NameErtapenem Sodium
Drug Alias NameErtapenemum艾他培南钠Ertapenem厄他培南单钠盐尔他培南钠 +[13] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaDiabetic Foot +[21] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaPyelonephritis +[16] 
Approved Indications in ChinaComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaPyelonephritis +[7] 
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/21
Country/TerritoryUnited StatesBrazilEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme （Australia） Pty LtdMerck Sharp & Dohme BvLaboratoires Merck Sharp & Dohme-Chibret (Mirabel) +[5] 
Inactive CompaniesWayne State UniversityAssociacao Instituto Nacional De Cancer - IncaMerck Sharp & Dohme LLC
Active IndicationsComplicated Skin and Soft Tissue InfectionsCommunity Acquired PneumoniaDiabetic Foot +[16] 
Inactive IndicationsKidney Failure, ChronicSoft Tissue InfectionsSepsis +[5] 

Other Information

ATC CodeJ01DH03
Related LinksWikipediaDrugBankKEGG